Acrux

Man looking at his arm in mirror preparing to apply an Axiron product.

Acrux’s innovative transdermal drug delivery technology has led to the development and commercialisation of multiple pharmaceuticals, including AXIRON, a spray-on testosterone solution. This product provides a less invasive treatment with fewer fluctuations for people with testosterone deficiency, providing potentially thousands of users with the benefits of stable testosterone levels including improved bone density, mood and cognition.

Year established: 1998
Website: acrux.com.au